onist SarI, I1e8-ANG II did not antagonize ANG IV. De termination of nitric oxide synthase (NOS) activity in vitro or inhibition of NOS in vivo did not support a role for NO in the action of ANG IV. Key Words: Angiotensin IV-Cerebral blood flow-Subarachnoid hemorrhage Nitric oxide synthase-Cerebral arteries. et ai., 1991) and increases rat renal blood flow (Swanson et aI., 1992) . It has been suggested that ANG IV might stimulate the synthesis and release of endothelium-derived relaxing factor (EDRF) (Haberl et aI., 1991) . EDRF has been identified as nitric oxide (NO), and it is synthesized by the en zyme NO synthase (NOS) (Palmer et ai., 1987; Bredt and Snyder, 1989) . There is a loss of endo thelium-dependent relaxation in SAH, and impaired release of EDRF has been implicated in the patho physiology of cerebral vasospasm (Nakagomi et aI., 1987; Kim et aI., 1988) . The present experiment was designed to study whether ANG IV, by virtue of its vasodilating properties, could improve CBF or alter NOS activity in large cerebral arteries in the acute phase of SAH.
METHODS
The experimental drugs used were human ANG II (3-8) (ANG IV), SarI, I1e8-ANG II (SI-ANG II) (Peninsula Laboratories, Belmont, CA, U.S.A.), and Nw-nitro-L arginine methyl ester (L-NAME; Sigma Chemical Co., St. Louis, MO, U.S.A.).
Male Sprague-Dawley rats (275-390 g; Zivic-Miller, Zelienople, PA, U.S.A.) were used. For CBF studies, the rats were anesthetized with ketamine (150 mg/kg i.m.) and acepromazine (15 mg/kg i.m.). The animals were al lowed to breathe freely room air with supplemental oxy gen. MABP was measured from the left femoral artery.
Rectal temperature was maintained at 36.5-37SC. CBF was measured using laser-Doppler flowmetry as de scribed previously (Stromberg et al., 1993) .
High concentrations of ANG IV may interfere with ANG II receptors (Bennett and Snyder, 1976) . Therefore, to avoid any ANG II receptor-mediated responses, pre liminary experiments were conducted to determine a suit able dose of ANG IV. ANG IV at 5 I-lg/kg/min (n = 3) increased the MABP, indicating a likely effect on ANG II receptors. ANG IV at 1 I-lg/kg/min (n = 4) or saline (n = 4) did not alter MABP or CBF when infused intrave nously for 60 min without SAH.
SAH experiment
The atlantooccipital membrane was exposed and pierced with a 27-gauge needle. The tip of a PE-lO poly ethylene tubing was inserted into the cisterna magna, and CSF was aspirated to confirm the location.
SAH was induced by injecting 0. 3 ml fresh autologous arterial blood (or saline for volume control) into the cis terna magna via the polyethylene tubing over 1-2 min. MABP and laser-Doppler flowmetry signals were re corded continuously during the injection and for 60 min afterward on a Grass model 79 polygraph chart. Samples for blood gas analysis were taken from the right femoral artery before and 60 min after SAH.
ANG IV at 1 I-lg/kg/min (n = 11) or saline (n = 11) was infused with a microinjection pump starting 20 min after SAH and continuing throughout the experiment. When used, SI-ANG II (4 I-lg/kg/min i.v. ; n = 8) and L-NAME (3 mg/kg/min i. v.; n = 8) infusions were started 10 min before SAH (30 min before ANG IV) and continued throughout the experiment.
NOS activity
After CBF measurements,. the rats were decapitated and the arteries of the circle of Willis and the basilar artery were dissected and cleaned under a stereo micro scope. SAH brains were ascertained to contain blood widely distributed in the subarachnoid space and exten sive clotting around large arteries. The arteries were im mediately assayed for NOS activity as conversion of [3H]arginine to eHlcitrulline (Bredt and Snyder, 1989) . The arteries were incubated for 5 min at 3rC in pregassed (95% O2/5% CO2) Krebs-Ringer buffer containing 3 I-lCi/ ml [3H]L-arginine (Du Pont NEN, Boston, MA, U. S. A.; specific activity 36.1 Ci/mmol). The reaction was stopped with cold buffer containing 5 mM unlabeled L-arginine (Sigma) and 4 mM Na2-ethylenediaminetetraacetate. Af ter sonication of the tissue, the supernatants were vac uum dried, redissolved in 2 ml 20 mM N-2-hydroxyeth ylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 5.5), and loaded on columns of Dowex AG50WX-8 (100-200 mesh, sodium form) cation exchange resin (Bio-Rad Lab oratories, Richmond, CA, U. S. A. ). The columns were washed with 2 ml of the same HEPES buffer and the 4-ml flow-through containing the formed [3H]citrulline was counted for radioactivity. Protein content was measured with the Bradford method (Bio-Rad).
To exclude positively an effect of ANG IV on NOS activity in the preparation of interest, basilar arteries from naive rats were examined. After 45-min preincuba tion in Krebs-Ringer buffer at 37°C, the arteries were incubated with the indicated drugs for 5 min (see Fig. 2 ). The NOS activity was measured as described previously.
Statistics
The CBF, MABP, and blood gas values were evaluated by two-way repeated measures analysis of variance (treatment x time) and, if necessary, one-way analysis of variance and Tukey's test. The NOS data were compared with one-way analysis of variance and Tukey's test. All results are expressed as means ± SD.
RESULTS
Baseline MABPs (mm Hg) were 84 ± 16 for SAHI saline, 80 ± 11 for SAHI AN G IV, 84 ± 10 for no SAH/saline, and 80 ± 6 for no SAHIANG IV. In SAHIANG IV and SAH/saline groups, injection of blood transiently increased MABP, but it returned to baseline within 5 min and remained at this level throughout the experiment. On the contrary, L-NAME increased and SI-ANG II lowered MABP.
These effects lasted throughout the experiment.
Since this complicates the comparison with the other two groups, the MABP and CBP data for SAH/L-NAME + ANG IV and SAH/SI -ANG II + ANG IV are shown separately in Table 1 .
Sixty-minute infusion of saline or ANG IV with out SAH did not alter CBP (98 ± 13 and 98 ± 16%; respectively) . Injection of 0.3 ml saline into the cisterna magna did not affect CBP (data not shown). Injection of blood immediately decreased CBP, which stabi lized after 10--15 min at �45% of baseline. At 20 min, all SAH groups were different from both groups without SAH (p < 0.01 for all SAH versus no SAH comparisons; Tukey's test). The severity of CBP reduction at 20 min was similar in all SAH groups. CBP in the SAH/saline group remained low for the duration of the experiment (45 ± 14 and 51 ± 17% at 20 and 60 min, respectively). On the con trary, infusion of ANG IV returned CBP close to baseline (46 ± 7 and 84 ± 38% at 20 and 60 min, respectively) (Pig. 1), and it was not different from the groups in which no SAH was produced. At 60 min, the CBP values in SAH/L-NAME + ANG IV Values are means ± SD. Times are relative to induction of SAH.
L-NAME and SI-ANG II infusions were started at -10 min. ANG IV infusion was started at 20 min. For abbreviations see the text. and SAH/SI-ANG II + ANG IV groups were not statistically different from those of SAHI ANG IV.
Arterial blood gas values were in the normal range and did not differ between the experimental groups (data not shown).
The NOS activities in large cerebral arteries after CBF experiments are shown in Table 2 . In naive basilar arteries, ANG IV did not affect NOS activ ity, whereas L-NAME inhibited eH]citrulline for mation by 58% (Fig. 2) .
DIS CUS S ION
The main finding of the present study is that ANG IV reverses the acute CBF reduction after SAH.
Recently, a distinct binding site for ANG IV was found in a variety of tissues from several species (Swanson et aI. , 1992) . This binding site is pharma cologically different from ANG II AT1 and AT2 re ceptors, and it has been named the angiotensin AT4 receptor (Wright et aI. , 1993) . This new receptor is Values are means ± SD. NOS activity was measured as con version of [3H]arginine to [3H]citrulline. There are no statisti cally significant differences between groups (Tukey's test, n = 8 for SAH groups and n = 4 for groups without SAH). For abbre viations see the text. ANG II receptors, specifically the AT2 subtype, have earlier been linked with CBF regulation in rat (Stromberg et aI., 1992 (Stromberg et aI., , 1993 Naveri et aI., 1994) .
However, the inability of SI-ANG II to antagonize the effect of ANG IV in the present study excludes the interaction of ANG IV with ANG II receptors (Swanson et aI. , 1992; Naveri et aI. , 1994) . In the present experiment, we did not find any differences in NOS activities between animals with and without SAH, indicating that synthesis of NO in large cerebral arteries probably does not change in the acute phase after SAH. In support of this, Kim et aI. (1989) demonstrated that EDRF release from canine basilar artery is not impaired in the late vasospasm after SAH, and the loss of endothelium dependent relaxation is likely to be due to reduced responsiveness of the smooth muscle or defective transfer of EDRF. Of course, we cannot exclude the possibility that NOS activity in smaller vessels could have changed. Unfortunately, due to tissue limitations, the NOS activity in cerebral arterioles after SAH could not be determined. The inability of L-NAME to antagonize the CBF effect of ANG IV argues against NO being the mediator of this re sponse. Again, as a word of caution, the hyperten sive effect of L-NAME could have offset a possible antagonistic effect.
In conclusion, we have demonstrated that intra venous infusion of ANG IV reverses the acute CBF reduction after experimental SAH in the rat. The mechanism of action of ANG IV could not be con firmed. This preliminary finding may have broader significance for treatment of SAH. This should be assessed in future studies using experimental SAH models in other species and examining a possible beneficial effect of ANG IV on delayed vasospasm and survival.
